Did Maximus beat or miss consensus estimates last quarter?

What guidance did Maximus's management provide for the next earnings period?

What is Maximus's gross profit margin?

What does Maximus do and what are its main business segments?

What were the key takeaways from Maximus’s earnings call?

What is the market's earnings forecast for Maximus next quarter?

What is the revenue and EPS growth rate for Maximus year over year?

What were the key takeaways from Maximus's earnings call?

- **Strong Financial Performance**: 2025 revenue $5.43B, adjusted EBITDA margin 12.9%, free cash flow $366M. 2026 guidance reflects 13.7% EBITDA margin and $8.10 EPS midpoint.
- **AI-Driven Growth**: 30 AI deployments planned for 2026, including TXM platform for government CX. Defense sector contracts (e.g., $86M Air Force deal) highlight strategic expansion.
- **Policy Opportunities**: SNAP compliance urgency driving state engagement; Medicaid work requirements may create long-term growth.
- **Capital Allocation**: $457M shares repurchased in 2025; M&A focus on defense and tech-enabled solutions.

**【Management Opening Remarks】**
- James Francis provided standard disclaimers regarding forward-looking statements and non-GAAP financial measures, emphasizing the importance of reviewing SEC filings for full risk disclosures.

**【CEO Summary Section】**
- **Fiscal Year 2025 Highlights**: Organic growth of 3.9%, with U.S. Federal Services segment delivering 12.1% growth. Customer retention remained strong, with only 0.5% of revenue impacted by cancellations.
- **Strategic Priorities for 2026**: Expansion in U.S. federal markets, policy-driven initiatives (e.g., One Big Beautiful Bill Act), and AI deployment. TXM platform, an AI-infused CX solution, is being tested by customers.
- **Defense Sector Growth**: Won a $86 million Air Force contract, expanding into defense and national security markets through OTAs and CRADAs.
- **Policy Impact**: Medicaid and SNAP compliance efforts are creating opportunities, with 30 AI-related deployments planned for 2026.

**【CFO Financial Commentary】**
- **2025 Financial Results**: Revenue $5.43 billion, adjusted EBITDA margin 12.9%, adjusted EPS $7.36. Free cash flow $366 million, net debt 1.5x EBITDA.
- **2026 Guidance**: Revenue $5.225-$5.425 billion (midpoint $5.325B), adjusted EBITDA margin 13.7%, EPS $7.95-$8.25. Free cash flow $450-$500 million.
- **Key Drivers**: Cost management (e.g., $16M severance charges in Q4), technology adoption, and disciplined capital allocation (shares repurchased $457M in 2025).

**【Q&A Key Highlights】**
- **Margin Expansion**: Driven by technology adoption, cost management, and reduced severance costs in 2026. U.S. Federal Services margin expected to improve to 15.5%-16%.
- **Government Shutdown Impact**: Minimal operational disruption; Q1 2026 cash flow may be delayed but expected to recover.
- **M&A Focus**: Defense and national security opportunities with access to customer relationships, technical capabilities, and business systems.
- **Policy Update**: SNAP error rate compliance urgency driving RFI/RFP activity; Medicaid work requirements may take longer to implement.


Maximus, Inc. (MMS) Q4 2025 Earnings Call Transcript

- **Record Q3 Results**: $1.35B revenue (+4.3% organic), $2.16 EPS (24% YoY), 15% EBITDA growth, and 18.1% U.S. Federal margin highlight strong execution.
- **Federal Tech Expansion**: $77M DoD win and CMMC Level 2 certification position Maximus for defense growth, with FY26 pipeline opportunities.
- **Policy-Driven Growth**: Medicaid work requirements (2027+), SNAP compliance, and state outsourcing could drive U.S. Services into double-digit growth.
- **Cash Flow Recovery**: Q4 collections expected to reduce DSO to normal levels, supporting $370-390M free cash flow guidance.
- **FY26 Outlook**: Revenue near FY25 levels with 13% EBITDA margin, poised for acceleration in FY27 with legislative implementations.

**【CEO Summary Section】**
- Q3 2025 revenue reached $1.35 billion, up 4.3% organically YoY, with adjusted EPS of $2.16 (24% YoY growth) and 15% adjusted EBITDA growth.
- U.S. Federal Services segment revenue grew 11.4% to $761 million, driven by clinical portfolio demand and operating margin expansion to 18.1%.
- Secured $77 million DoD contract for cybersecurity and cloud services, achieving CMMC Level 2 certification to expand federal tech opportunities.
- Positioned to benefit from the One Big Beautiful Bill Act, with potential Medicaid and SNAP compliance work starting in 2027, and signed a state SNAP contract modification post-quarter close.
- FY26 guidance cautious due to volume moderation and budget uncertainties, but sees long-term growth from policy changes and adjacent federal markets.

**【CFO Financial Commentary】**
- Q3 2025 adjusted EBITDA margin of 14.7% (vs. 13.1% YoY), driven by operating leverage on incremental volumes.
- U.S. Services segment margin at 10.2% (down from 13.0% YoY due to prior year Medicaid unwinding benefits).
- Cash flow challenges with DSO at 96 days, but $300 million+ collections in July and $224 million AR conversion in Q3 suggest Q4 improvement.
- Raised FY25 guidance: revenue $5.375-$5.475 billion (midpoint +$100M), adjusted EPS $7.35-$7.55 (midpoint +$1.60), and free cash flow $370-$390 million.
- FY26 early view: revenue near FY25 levels, EBITDA margin near 13%, and interest expense reduction.

**【Q&A Key Highlights】**
- **Legislative Opportunities**: Medicaid work requirements (2027+ implementation) and SNAP error rate compliance could lift U.S. Services growth to mid-single to low double digits. Conflict-free positioning advantageous for state contracts.
- **Defense Expansion**: Air Force cybersecurity win and CMMC Level 2 certification signal intent to grow defense tech business, with pipeline opportunities in federal efficiency initiatives.
- **VA Claims Processing**: Q3 2025 packed/nonpacked claims up 23% sequentially to 800k+ due to capacity investments, but expect moderation as VA nears backlog goals. Sustained clinical volume growth expected.
- **Financial Flexibility**: Resuming M&A and share buybacks ($66M remaining under $200M authorization) as cash flow normalizes post-Q3 collections.


Maximus, Inc. (MMS) Q3 2025 Earnings Call Transcript

- **Revenue Growth**: $1.36B Q2 revenue, 3% organic growth, driven by Federal clinical assessments and AI innovations.
- **Profitability**: Adjusted EBITDA margin 13.7%, FY25 guidance raised to 11.7% margin, $6.30-$6.60 EPS.
- **AI Impact**: Automation cuts dispute resolution backlog by 50%, VA records processing time reduced by 75%.
- **Pipeline Strength**: $41.2B pipeline, 25% increase in proposals, 60% in U.S. Federal Services.
- **International Restructuring**: Outside U.S. organic growth 4.6%, U.K. contract driving margin improvement.
- **Risk Management**: Cautious guidance reflects macro uncertainty, $4M FY25 revenue impact from DOGE.

**【CEO Summary Section】**
- Reported Q2 revenue of $1.36 billion, with 3% organic growth year-over-year.
- Adjusted EBITDA margin of 13.7%, within near-term guidance range.
- Federal segment growth driven by clinical assessments and AI innovations (e.g., No Surprises Act dispute resolution automation, VA records processing AI).
- DOGE impact limited to $4 million FY25 revenue reduction, with focus on innovation and efficiency.
- State-level 'Flexibility to Contract' framework reactivated, supporting hybrid public-private models.
- Pipeline at $41.2 billion, 55% new work, 60% in U.S. Federal Services.
- Recognized as one of Fortune's most innovative companies for AI/automation adoption.

**【CFO Financial Commentary】**
- Q2 GAAP revenue $1.36B, adjusted EBITDA $185M (13.7% margin), adjusted EPS $2.01.
- U.S. Federal Services revenue +10.9% ($778M), driven by clinical assessments and automation efficiencies.
- U.S. Services revenue -9% ($442M) due to Medicaid unwinding normalization, margin 12.2%.
- Outside U.S. revenue -10% ($142M), organic +4.6%, margin 3.4% (vs. 0.4% prior year).
- Free cash flow $26M, DSO 73 days (up from 62 days) due to delayed collections.
- Updated FY25 guidance: revenue $5.25B-$5.4B, adjusted EBITDA margin 11.7%, EPS $6.30-$6.60.
- U.S. Federal segment FY25 margin 12.5%-13%, U.S. Services 11%, Outside U.S. 3%-5%.
- Share repurchases $73M (947K shares), $66M remaining under $200M authorization.

**【Q&A Highlights】**
- **Guidance Moderation**: Q3/Q4 guidance unchanged to accommodate macro risks, with Q3 moderation from clinical volumes and seasonal work.
- **Margin Drivers**: AI/automation reducing manual effort, shifting staff to higher-value roles (e.g., quality assurance).
- **Pipeline Progress**: Proposals in preparation +25% QoQ, 25% of pipeline in U.S. Federal Services.
- **International Growth**: U.K. Functional Assessment Services contract driving 4.6% organic growth, restructuring reducing overhead.
- **Pricing Concessions**: Fielding requests for pricing adjustments, maintaining cautious stance on FY25 outlook.


Maximus (MMS)-8 May 25-2025 Q2 Earnings call transcript

- **Core Contracts Secured**: CCO through 2031 and VA MDE re-awarded, ensuring $1.5B+ annual revenue stability.
- **Profitability Boost**: Australian/SKorea divestitures expected to add 200-300bps to segment margin by FY25.
- **DigitalGov Opportunity**: Leading federal tech modernization efforts with 100+ government IT projects in pipeline.
- **Medicaid Resilience**: Volume-based contracts shield from enrollment declines; state exchange integration preserves 70%+ Medicaid attrition consumers.
- **Balance Sheet Strength**: $200M buyback authorization underscores confidence; net debt/EBITDA <1x.

**【CEO Summary Section】**
- **Contract Wins and Stability**: Secured continuation of the CMS Contact Center Operations (CCO) contract through 2031 and re-awarded VA Medical Disability Examination (MDE) contracts, ensuring uninterrupted service delivery.
- **Business Restructuring**: Completed divestiture of Australian and South Korean employment services, reducing segment volatility and improving profitability in FY2025+.
- **Share Repurchase Program**: Authorized $200 million stock buyback, with CFO to provide execution updates.
- **Government Partnership Strength**: Highlighted resilience of core Medicare and Veterans Benefits programs, which were exempt from recent federal hiring freeze and funding pause.
- **DOGE/USDS Alignment**: Positioned as a key partner in federal technology modernization, leveraging expertise in software development and IT systems.
- **Medicaid Dynamics**: Noted potential volume increases from eligibility verification steps and state-level contingency planning for federal policy changes, with opportunities to tailor solutions.
- **State Exchange Integration**: Maintained consumer engagement through state-based exchanges, mitigating risks of Medicaid eligibility changes.

MMS

MMS fundamentals

Earnings Call

You can ask Aime